ALEX vs EW · P/E 23, rev $236.6M vs P/E 47, rev $1.39B
Alexander & Baldwin Holdings Inc (ALEX) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Alexander & Baldwin Holdings Inc (ALEX) is a reit - retail company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported ALEX revenue for 2024-12-31 was $236.6M. Net income was $60.5M. Revenue was up 13.3% from 2023-12-31 to 2024-12-31. ALEX currently screens at market cap $1.52B and trailing P/E 23.4.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
ALEX currently screens at market cap $1.52B and trailing P/E 23.4. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the ALEX and EW stock pages for the full models.
Not investment advice.